miR-375 and miR-30d in the Effect of Chromium-Containing Chinese Medicine Moderating Glucose Metabolism

الملخص EN

In China, TianMai Xiaoke tablet (TM) is used to treat type 2 diabetes.

However, the exact mechanism of TM is not clear.

This study is to investigate the effect of TM on glucose metabolism in diabetic rats and to identify whether TM takes a direct action through microRNAs on islet.

Rats were divided into control group, diabetic group, low dose of TM group (TML), and high dose of TM group (TMH).

Pancreas samples were analyzed using microRNA array and Q-PCR.

Eight-week treatment with TM significantly decreased fasting blood glucose.

The blood glucose was significantly reduced in TM-treated groups before and after oral glucose administration.

Fasting insulin and HOMA-IR were suppressed in TM-treated groups.

miR-448, let-7b, miR-540, miR-296, miR-880, miR-200a, miR-500, miR-10b, miR-336, miR-30d, miR-208, let-7e, miR-142-5p, miR-874, miR-375, miR-879, miR-501, and miR-188 were upregulated, while miR-301b, miR-134, and miR-652 were downregulated in TMH group.

Through target gene analysis and real-time PCR verification, we found that these miRNAs, especially miR-375 and miR-30d, can stimulate insulin secretion in islet.

Our data suggest that TM can improve blood glucose in diabetic rats which involved increasing the expression of miR-375 and miR-30d to activate insulin synthesis in islet.